BiosPacific has been working hard over the past few months to bring some new and clinically relevant antibodies and proteins to market. Our current featured products focus on the Traumatic Brain Injury biomarkers, these targets represent a cutting-edge portfolio of diagnostic tools designed to advance the field of clinical diagnostics.
